Journal Title：Liver Cancer

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal ‘Liver Cancer’ serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. 'Liver Cancer' publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.

肝癌在癌癥中發病率極高，是全球最常見的死亡原因之一。基于這些事實，《肝癌》雜志滿足了人們日益增長的需求，讓人們更好地了解這種惡性腫瘤的病因、機制和治療方法。它為國際研究人員和臨床醫生提供了一個平臺，展示他們的研究成果，重點關注該疾病的分子致癌作用、預防、監測、診斷和治療，包括分子靶向治療。《肝癌》以原創和評論文章的形式發表與人類和實驗模型肝癌領域相關的臨床和轉化研究。

Liver Cancer創刊于2012年，由S. Karger AG出版商出版，收稿方向涵蓋Oncology - Medicine全領域，在行業領域中學術影響力很大，屬于國際一流期刊，關注度和專業度非常高，所以對原創文章要求創新性很高，過審難度很高，如果您有志于一流期刊，建議關注此刊。平均審稿速度 16 Weeks ，影響因子指數11.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。